Structural and Evolutionary Basis for the Dual Substrate Selectivity of Human KDM4 Histone Demethylase Family

被引:138
|
作者
Hillringhaus, Lars [1 ,2 ]
Yue, Wyatt W. [3 ]
Rose, Nathan R. [1 ,2 ]
Ng, Stanley S. [3 ]
Gileadi, Carina [3 ]
Loenarz, Christoph [1 ,2 ]
Bello, Simon H. [1 ,2 ]
Bray, James E. [3 ]
Schofield, Christopher J. [1 ,2 ]
Oppermann, Udo [3 ,4 ]
机构
[1] Univ Oxford, Dept Chem, Oxford OX1 3TA, England
[2] Univ Oxford, Oxford Ctr Integrat Syst Biol, Chem Res Lab, Oxford OX1 3TA, England
[3] Univ Oxford, Struct Genom Consortium, Headington OX3 7DQ, England
[4] Botnar Res Ctr, Natl Inst Hlth Res Oxford Biomed Res Unit, Nuffield Dept Orthoped Rheumatol & Musculoskeleta, Oxford OX3 7LD, England
基金
英国生物技术与生命科学研究理事会; 英国惠康基金;
关键词
LINKED MENTAL-RETARDATION; JMJD2; FAMILY; ANDROGEN RECEPTOR; JUMONJI-DOMAIN; JARID1C GENE; PHF8; METHYLATION; MUTATIONS; HYPOXIA; SPECIFICITY;
D O I
10.1074/jbc.M111.283689
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
N-epsilon-Methylations of histone lysine residues play critical roles in cell biology by "marking" chromatin for transcriptional activation or repression. Lysine demethylases reverse Art-methylation in a sequence- and rnethylation-selective manner. The determinants of sequence selectivity for histone demethylases have been unclear. The human JMJD2 (KDM4) H3K9 and H3K36 demethylases can be divided into members that act on both H3K9 and H3K36 and H3K9 alone. Kinetic, crystallographic, and mutagenetic studies in vitro and in cells on KDM4A-E reveal that selectivity is determined by multiple interactions within the catalytic domain but outside the active site. Structurally informed phylogenetic analyses reveal that KDM4A-C orthologues exist in all genome-sequenced vertebrates with earlier animals containing only a single KDM4 enzyme. KDM4D orthologues only exist in eutherians (placental mammals) where they are conserved, including proposed substrate sequence-determining residues. The results will be useful for the identification of inhibitors for specific histone demethylases.
引用
收藏
页码:41616 / 41625
页数:10
相关论文
共 50 条
  • [21] Substrate- and Cofactor-independent Inhibition of Histone Demethylase KDM4C
    Leurs, Ulrike
    Lohse, Brian
    Rand, Kasper D.
    Ming, Shonoi
    Riise, Erik S.
    Cole, Philip A.
    Kristensen, Jesper L.
    Clausen, Rasmus P.
    ACS CHEMICAL BIOLOGY, 2014, 9 (09) : 2131 - 2138
  • [22] Structural insight into substrate recognition by histone demethylase LSD2/KDM1b
    Chen, Fei
    Yang, Huirong
    Dong, Zhenghong
    Fang, Jian
    Wang, Ping
    Zhu, Tingting
    Gong, Wei
    Fang, Rui
    Shi, Yujiang Geno
    Li, Ze
    Xu, Yanhui
    CELL RESEARCH, 2013, 23 (02) : 306 - 309
  • [23] Structural insight into substrate recognition by histone demethylase LSD2/KDM1b
    Fei Chen
    Huirong Yang
    Zhenghong Dong
    Jian Fang
    Ping Wang
    Tingting Zhu
    Wei Gong
    Rui Fang
    Yujiang Geno Shi
    Ze Li
    Yanhui Xu
    Cell Research, 2013, 23 : 306 - 309
  • [24] KDM6 and KDM4 histone lysine demethylases emerge as molecular therapeutic targets in human acute myeloid leukemia
    Boila, Liberalis Debraj
    Chatterjee, Shankha Subhra
    Banerjee, Debasis
    Sengupta, Amitava
    EXPERIMENTAL HEMATOLOGY, 2018, 58 : 44 - 51
  • [25] Structural analysis of human KDM5B guides histone demethylase inhibitor development
    Johansson C.
    Velupillai S.
    Tumber A.
    Szykowska A.
    Hookway E.S.
    Nowak R.P.
    Strain-Damerell C.
    Gileadi C.
    Philpott M.
    Burgess-Brown N.
    Wu N.
    Kopec J.
    Nuzzi A.
    Steuber H.
    Egner U.
    Badock V.
    Munro S.
    Lathangue N.B.
    Westaway S.
    Brown J.
    Athanasou N.
    Prinjha R.
    Brennan P.E.
    Oppermann U.
    Nature Chemical Biology, 2016, 12 (7) : 539 - 545
  • [26] Structural analysis of human KDM5B guides histone demethylase inhibitor development
    Johansson, Catrine
    Velupillai, Srikannathasan
    Tumber, Anthony
    Szykowska, Aleksandra
    Hookway, Edward S.
    Nowak, Radoslaw P.
    Strain-Damerell, Claire
    Gileadi, Carina
    Philpott, Martin
    Burgess-Brown, Nicola
    Wu, Na
    Kopec, Jola
    Nuzzi, Andrea
    Steuber, Holger
    Egner, Ursula
    Badock, Volker
    Munro, Shonagh
    LaThangue, Nicholas B.
    Westaway, Sue
    Brown, Jack
    Athanasou, Nick
    Prinjha, Rab
    Brennan, Paul E.
    Oppermann, Udo
    NATURE CHEMICAL BIOLOGY, 2016, 12 (07) : 539 - +
  • [27] Synthesis and Characterisation of Substrate-Based Peptides as Inhibitors of Histone Demethylase KDM4C
    Nielsen, Simon D.
    Leurs, Ulrike
    Bergner, Magnus
    Barris, Silvia A.
    Devkota, Kanchan
    Meyer, Kamilla
    Iaria, Daniella
    McCaughan, Jack
    Lohse, Brian
    Kristensen, Jesper L.
    Clausen, Rasmus P.
    PROTEIN AND PEPTIDE LETTERS, 2016, 23 (09): : 772 - 776
  • [28] Inhibition of cancer stem cells with TACH101, a first-in-class inhibitor of KDM4 histone lysine demethylase.
    Perabo, Frank
    Chandhasin, Chandtip
    Dang, Van
    Del Rosario, Joselyn
    Chen, Young K.
    Filvaroff, Ellen
    Stafford, Jeffrey
    Quake, Stephen
    Clarke, Michael F.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [29] Histone Lysine Demethylases of JMJD2 or KDM4 Family are Important Epigenetic Regulators in Reward Circuitry in the Etiopathology of Depression
    Salil Saurav Pathak
    Swati Maitra
    Sumana Chakravarty
    Arvind Kumar
    Neuropsychopharmacology, 2017, 42 : 854 - 863
  • [30] TACH101, a first-in-class inhibitor of KDM4 histone lysine demethylase for the treatment of diffuse large B-cell lymphoma
    Perabo, Frank
    Chandhasin, Chandtip
    Yoo, Sanghee
    Del Rosario, Joselyn
    Chen, Young K.
    Filvaroff, Ellen
    Stafford, Jeffrey A.
    Quake, Stephen
    Clarke, Michael F.
    CANCER RESEARCH, 2022, 82 (12)